To request a copy of the Program of Excellence in Extended Care, please contact Verathon(TM) at 800.331.2313 or download a copy at http://www.verathon.com/ECManual.htm .

CONTACT: Jane Mueller, VP of Marketing, ext. 6060, or Joyce Chee,Executive Assistant - Marketing, ext. 6064, or Jessica McNerney, ExecutiveAssistant to Gerald McMorrow, ext. 1448, all of Verathon Inc.,+1-425-867-1348

© 2024 Robert W. Baird & Co. Incorporated. The services featured on this web site may not be available in all jurisdictions or to all persons/entities.For more information, please see Important Disclosures. Robert W. Baird & Co. Incorporated. Member SIPC.

BOTHELL, Wash., Jan. 10 /PRNewswire/ -- Verathon Inc. is pleased to introduce the new, revised edition of the Program of Excellence in Extended Care by world-renowned continence expert Diane K. Newman, RNC MSN, CRNP FAAN, Co-Director of the Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Medical Center, in Philadelphia.

The Program of Excellence can help Extended Care facilities achieve and maintain compliance with the revised FTag regulations. The Program of Excellence is a continuing education program that teaches Extended Care staff how to provide the best care for residents with bladder conditions, including urinary incontinence, urinary retention, and urinary tract infection (UTI). The program covers toileting assistance programs, behavior modification strategies, bladder rehabilitation techniques, environmental accommodation, and device and product management. By studying the program and completing a post-test, Extended Care staff can receive 5.0 CE credits from SUNA (Society of Urologic Nurses and Associates).

Noninvasive bladder volume measurement using ultrasound is an integral part of the Program of Excellence. The BladderScan(R) bladder volume instrument from Verathon(TM) (formerly Diagnostic Ultrasound) is considered the gold standard for bladder volume measurement. Its many applications in Extended Care include helping staff to assess residents for urinary retention, evaluate the need for catheterization, and implement volume-based toileting programs.

“By implementing an effective bladder assessment and management program, healthcare providers can help many residents to regain control of their bladder function,” said Newman.

NOTE: BladderScan(R), Verathon(TM), and Verathon Medical(TM) are either registered trademarks or trademarks of Verathon Inc. in the United States and/or other countries.

With the June 2005 revisions to the FTag legislation that regulates treatment of incontinence in the nursing home, the CMS recognized the importance of proper assessment and care for residents with incontinence. To maintain compliance and to avoid fines, facilities must ensure that bladder conditions are appropriately addressed.

From Fortune. ©2024 Fortune Media IP Limited All rights reserved. Fortune and Fortune 100 Best Companies to Work For® are registered trademarks of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Baird.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comVerathon Inc.

Based on MDS (Minimum Data Set) and CMS (Centers for Medicare and Medicaid Services) FTag 315 regulations for the assessment of residents with bladder dysfunction, the Program of Excellence was written to assist Extended Care facilities implement an effective bladder assessment and management program that minimizes incontinence among residents.

Verathon(TM), formerly Diagnostic Ultrasound Corp., designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company’s noninvasive BladderScan(R) instrument is the gold standard in bladder volume measurement. The brand is found in over 60 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon(TM) entered Anesthesiology, Critical Care and Emergency markets with the GlideScope(R) Video Laryngoscope brand. Recently experiencing double-digit growth, Verathon(TM) was ranked among the fastest growing technology companies in Washington State for both 2005 and 2006 in Deloitte’s prestigious “Technology Fast 50" program. Verathon(TM) is headquartered in Bothell, Washington and has approximately 270 employees worldwide. For more information, please visit www.verathon.com.

It is estimated that 50% of residents in Long Term Care facilities are incontinent(1). While it is commonly assumed that incontinence is an inevitable result of aging, according to Newman, this is not the case.

PartsSource, Inc. (“PartsSource” or the “Company”), a portfolio company of Great Hill Partners, LP (“Great Hill”), has been acquired by Bain Capital, LP (“Bain”). Terms of the transaction were not disclosed. Baird served as the exclusive financial advisor to PartsSource, Inc. on this transaction.

Media Contact: Jane Mueller, VP of Marketing of Verathon Medical Inc., 425.867.1348, Ext. 6060. Alternate Contacts: Joyce Chee, Executive Assistant - Marketing 425.867.1348, Ext. 6064; or Jessica McNerney, Executive Assistant to Gerald McMorrow, Verathon Inc., 425.867.1348, Ext. 1448.

If you are interested in learning more about BladderScan(R) specifically for Extended Care facilities, please direct U.S. based inquiries to Direct Supply, exclusive Long Term Care distributor of BladderScan(R) in the U.S., at 1.800.634.7328, or visit www.DirectSupply.net. Facilities that contact Direct Supply may request a free copy of Direct Supply’s F-Tag 315 Revisions: Urinary Incontinence and BladderScan(R) Guide. For international inquiries, please contact Mike Rothmeyer at Verathon Medical Inc. at +1.425.867.1348, Ext. 1121.